Impact of the COBAS AmpliPrep/COBAS AMPLICOR HIV-1 MONITOR Test, version 1.5, on clinical laboratory operations

Jeffrey J. Germer, Jordan L. Bendel, Craig A. Dolenc, Sarah R. Nelson, Amanda L. Masters, Tara M. Gerads, Jayawant N. Mandrekar, P. Shawn Mitchell, Joseph D.C. Yao

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

The COBAS AmpliPrep/COBAS AMPLICOR HIV-1 MONITOR Test, version 1.5 (CAP/CA), and the COBAS AMPLICOR HIV-1 MONITOR Test, version 1.5, were compared. CAP/CA reduced and consolidated labor while modestly increasing assay throughput without increased failure rates or direct costs, regardless of batch size and assay format.

Original languageEnglish (US)
Pages (from-to)3101-3104
Number of pages4
JournalJournal of clinical microbiology
Volume45
Issue number9
DOIs
StatePublished - Sep 2007

ASJC Scopus subject areas

  • Microbiology (medical)

Fingerprint Dive into the research topics of 'Impact of the COBAS AmpliPrep/COBAS AMPLICOR HIV-1 MONITOR Test, version 1.5, on clinical laboratory operations'. Together they form a unique fingerprint.

  • Cite this

    Germer, J. J., Bendel, J. L., Dolenc, C. A., Nelson, S. R., Masters, A. L., Gerads, T. M., Mandrekar, J. N., Mitchell, P. S., & Yao, J. D. C. (2007). Impact of the COBAS AmpliPrep/COBAS AMPLICOR HIV-1 MONITOR Test, version 1.5, on clinical laboratory operations. Journal of clinical microbiology, 45(9), 3101-3104. https://doi.org/10.1128/JCM.00656-07